Page last updated: 2024-11-12

epiquinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

epiquinamide: quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11241028
CHEMBL ID460758
SCHEMBL ID2464033
MeSH IDM0460037

Synonyms (4)

Synonym
CHEMBL460758
SCHEMBL2464033
epiquinamide
n-[(1r,9ar)-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-1-yl]acetamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID356557Agonist activity at rat nicotinic alpha3beta4 receptor expressed in human KXalpha-3-beta-4R2 cells at 50 uM by cell based membrane potential assay relative to (+/-)-epibatidine2003Journal of natural products, Oct, Volume: 66, Issue:10
Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
AID356554Agonist activity at human nicotinic alpha-1-beta-1-gamma-delta receptor expressed in human TE-671 cells at 50 uM by cell based membrane potential assay relative to (+/-)-epibatidine2003Journal of natural products, Oct, Volume: 66, Issue:10
Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
AID356555Agonist activity at human nicotinic alpha3beta2 receptor expressed in human SH-SY5Y cells at 50 uM by cell based membrane potential assay relative to (+/-)-epibatidine2003Journal of natural products, Oct, Volume: 66, Issue:10
Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
AID356558Agonist activity at human nicotinic alpha4beta2 receptor expressed in human K177 cells at 50 uM by cell based membrane potential assay relative to (+/-)-epibatidine2003Journal of natural products, Oct, Volume: 66, Issue:10
Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
AID356556Agonist activity at human nicotinic alpha3beta4 receptor expressed in human IMR32 cells at 50 uM by cell based membrane potential assay relative to (+/-)-epibatidine2003Journal of natural products, Oct, Volume: 66, Issue:10
Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]